STOCK TITAN

[8-K] Lifeward Ltd. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Lifeward Ltd. (LFWD) reported preliminary, unaudited Q3 results for the quarter ended September 30, 2025. The company estimates revenue of approximately $6.2 million and U.S. GAAP operating expenses of about $5.8–$5.9 million for the period.

Liquidity at quarter-end was limited, with cash and cash equivalents of approximately $2.0 million as of September 30, 2025. The company also stated its cash, cash equivalent and short‑term investment balance was approximately $2.0 million as of the same date.

Management prepared these figures and they are subject to customary quarter-end close procedures, which could change the amounts. The company’s independent auditor, EY, has not audited, reviewed, or compiled these results. Actual results will appear in the upcoming Form 10‑Q. The information was furnished under Item 2.02 and is not deemed filed under the Exchange Act.

Lifeward Ltd. (LFWD) ha riportato risultati preliminari non certificati del Q3 per il trimestre terminato il 30 settembre 2025. L'azienda stima ricavi di circa 6,2 milioni di dollari e costi operativi secondo US GAAP di circa 5,8–5,9 milioni di dollari per il periodo.

La liquidità al termine del trimestre era limitata, con liquidità e equivalenti di circa 2,0 milioni di dollari al 30 settembre 2025. L'azienda ha anche dichiarato che il saldo di contante, equivalenti di contante e investimenti a breve termine era di circa 2,0 milioni di dollari alla stessa data.

La direzione ha predisposto queste cifre e sono soggette alle consuete procedure di chiusura di trimestre, che potrebbero modificare gli importi. L'auditor indipendente della società, EY, non ha audittato, revisionato o compilato questi risultati. I risultati effettivi saranno pubblicati nel prossimo Form 10‑Q. L'informativa è stata fornita ai sensi dell'Item 2.02 e non è considerata depositata ai sensi della Exchange Act.

Lifeward Ltd. (LFWD) informó resultados preliminares no auditados del tercer trimestre para el trimestre terminado el 30 de septiembre de 2025. La compañía estima ingresos de aproximadamente $6.2 millones y gastos operativos según US GAAP de alrededor de $5.8–$5.9 millones para el período.

La liquidez al cierre del trimestre fue limitada, con efectivo y equivalentes de aproximadamente $2.0 millones al 30 de septiembre de 2025. La compañía también declaró que su saldos de efectivo, equivalentes de efectivo y inversiones a corto plazo eran aproximadamente $2.0 millones en la misma fecha.

La dirección preparó estas cifras y están sujetas a los procedimientos habituales de cierre de trimestre, lo que podría cambiar las cantidades. El auditor independiente de la empresa, EY, no ha auditado, revisado ni compilado estos resultados. Los resultados reales aparecerán en el próximo Formulario 10-Q. La información fue facilitada conforme al Párrafo 2.02 y no se considera presentada conforme a la Exchange Act.

Lifeward Ltd. (LFWD)는 2025년 9월 30일 종료된 분기에 대한 예비적 무감사 Q3 실적을 보고했습니다. 회사는 기간에 대해 매출 약 620만 달러US GAAP 기준 영업비용 약 580만~590만 달러를 추정합니다.

분기 말 유동성은 제한적이었고 현금 및 현금성 자산은 2025년 9월 30일 현재 약 200만 달러였습니다. 회사는 또한 현금 및 현금성 자산과 단기투자 잔액이 같은 날짜에 약 200만 달러였다고 밝혔습니다.

경영진은 이 수치를 작성했으며 분기 말 마감 절차의 일반적 절차에 따라 변경될 수 있습니다. 회사의 독립 감사인 EY는 이 결과를 감사, 검토 또는 편집하지 않았습니다. 실제 결과는 향후 Form 10-Q에 표시될 예정입니다. 이 정보는 항목 2.02에 따라 제공되었으며 Exchange Act에 따라 제출된 것으로 간주되지 않습니다.

Lifeward Ltd. (LFWD) a déclaré des résultats préliminaires non audités du T3 pour le trimestre se terminant le 30 septembre 2025. La société estime un chiffre d'affaires d'environ 6,2 millions de dollars et des coûts opérationnels selon les principes comptables généralement admis aux États-Unis (US GAAP) d'environ 5,8–5,9 millions de dollars pour la période.

La liquidité à la fin du trimestre était limitée, avec des liquidités et équivalents d'environ 2,0 millions de dollars au 30 septembre 2025. La société a également indiqué que son solde de liquidités, équivalents de liquidité et investissements à court terme était d'environ 2,0 millions de dollars à la même date.

La direction a préparé ces chiffres et ils sont soumets aux procédures habituelles de clôture du trimestre, ce qui pourrait modifier les montants. L'auditeur indépendant de la société, EY, n'a pas audité, révisé ou compilé ces résultats. Les résultats réels apparaîtront dans le prochain Formulaire 10-Q. L'information a été fournie en vertu de l'Item 2.02 et n'est pas considérée comme déposée en vertu de la Exchange Act.

Lifeward Ltd. (LFWD) berichtete vorläufige, unprüfte Q3-Ergebnisse für das Quartal zum 30. September 2025. Das Unternehmen schätzt einen Umsatz von ca. 6,2 Mio. USD und US-GAAP-Betriebsausgaben von ca. 5,8–5,9 Mio. USD für den Zeitraum.

Liquidität zum Quartalsende war begrenzt, mit Barmitteln und Barmitteläquivalenten von ca. 2,0 Mio. USD zum 30. September 2025. Das Unternehmen gab außerdem an, dass sein Saldo an Barmitteln, Barmitteläquivalenten und kurzfristigen Investitionen zum selben Datum ca. 2,0 Mio. USD betrug.

Das Management hat diese Zahlen erstellt und sie unterliegen den üblichen Quartalsabschlussverfahren, die die Beträge ändern könnten. Der unabhängige Prüfer EY hat diese Ergebnisse nicht geprüft, überprüft oder zusammengestellt. Die tatsächlichen Ergebnisse werden im kommenden Form 10-Q erscheinen. Die Informationen wurden gemäß Item 2.02 bereitgestellt und gelten nicht als gemäß der Exchange Act eingereicht.

Lifeward Ltd. (LFWD) أبلغت عن نتائج مبدئية غير مدققة للربع الثالث للسنة المنتهية في 30 سبتمبر 2025. تقُدِّر الشركة الإيرادات بنحو 6.2 مليون دولار تقريباً وتكاليف تشغيل وفق US GAAP بنحو 5.8–5.9 مليون دولار لهذه الفترة.

السيولة في نهاية الربع كانت محدودة، مع النقد وما يساويه بنحو 2.0 مليون دولار حتى 30 سبتمبر 2025. كما ذكرت الشركة أن رصيد النقد وما يعادله والاستثمارات قصيرة الأجل كان يبلغ نحو 2.0 مليون دولار في التاريخ نفسه.

إدارة الشركة أعدت هذه الأرقام وهي خاضعة للإجراءات المعتادة لإغلاق الربع، والتي قد تغير الأعداد. لم يُدقق المدقق المستقل للشركة EY في هذه النتائج، ولا راجعها، ولا جمّعها. ستظهر النتائج الفعلية في النموذج 10-Q القادم. تم تقديم المعلومات بموجب البند 2.02 وليست مُعتبرة مُقدَّمة وفقاً لقانون التبادل.

Lifeward Ltd. (LFWD) 报告了截至 2025 年 9 月 30 日 季度的初步未经审计的第三季度业绩。公司估计本期收入约为 620 万美元,按美国公认会计原则(US GAAP)的运营成本约为 580 万至 590 万美元
季度末的流动性有限,现金及现金等价物约为 200 万美元(截至 2025 年 9 月 30 日)。公司还表示,其现金、现金等价物及短期投资余额在同一日期约为 200 万美元
管理层编制了这些数字,受常规季度末结账程序约束,可能会改变数额。公司的独立审计师 EY 尚未对这些结果进行审计、复核或汇编。实际结果将出现在即将发布的 Form 10-Q 中。信息是根据 Item 2.02 提供的,且不视为根据交易法案(Exchange Act 提交。)

Positive
  • None.
Negative
  • None.

Insights

Preliminary Q3 revenue ~$6.2M; cash ~$2.0M, unaudited.

Lifeward disclosed estimated Q3 revenue of $6.2M and U.S. GAAP operating expenses of $5.8–$5.9M for the quarter ended September 30, 2025. These figures provide an early look at activity but are management-prepared and subject to final close procedures.

Cash and cash equivalents were about $2.0M as of September 30, 2025, and the company also cited a cash, cash equivalent and short-term investment balance of $2.0M. The auditor (EY) has not performed procedures on these estimates.

The disclosure was furnished under Item 2.02, not filed. Actual results will be included in the forthcoming Form 10‑Q; amounts may change after completion of quarter-end review.

Lifeward Ltd. (LFWD) ha riportato risultati preliminari non certificati del Q3 per il trimestre terminato il 30 settembre 2025. L'azienda stima ricavi di circa 6,2 milioni di dollari e costi operativi secondo US GAAP di circa 5,8–5,9 milioni di dollari per il periodo.

La liquidità al termine del trimestre era limitata, con liquidità e equivalenti di circa 2,0 milioni di dollari al 30 settembre 2025. L'azienda ha anche dichiarato che il saldo di contante, equivalenti di contante e investimenti a breve termine era di circa 2,0 milioni di dollari alla stessa data.

La direzione ha predisposto queste cifre e sono soggette alle consuete procedure di chiusura di trimestre, che potrebbero modificare gli importi. L'auditor indipendente della società, EY, non ha audittato, revisionato o compilato questi risultati. I risultati effettivi saranno pubblicati nel prossimo Form 10‑Q. L'informativa è stata fornita ai sensi dell'Item 2.02 e non è considerata depositata ai sensi della Exchange Act.

Lifeward Ltd. (LFWD) informó resultados preliminares no auditados del tercer trimestre para el trimestre terminado el 30 de septiembre de 2025. La compañía estima ingresos de aproximadamente $6.2 millones y gastos operativos según US GAAP de alrededor de $5.8–$5.9 millones para el período.

La liquidez al cierre del trimestre fue limitada, con efectivo y equivalentes de aproximadamente $2.0 millones al 30 de septiembre de 2025. La compañía también declaró que su saldos de efectivo, equivalentes de efectivo y inversiones a corto plazo eran aproximadamente $2.0 millones en la misma fecha.

La dirección preparó estas cifras y están sujetas a los procedimientos habituales de cierre de trimestre, lo que podría cambiar las cantidades. El auditor independiente de la empresa, EY, no ha auditado, revisado ni compilado estos resultados. Los resultados reales aparecerán en el próximo Formulario 10-Q. La información fue facilitada conforme al Párrafo 2.02 y no se considera presentada conforme a la Exchange Act.

Lifeward Ltd. (LFWD)는 2025년 9월 30일 종료된 분기에 대한 예비적 무감사 Q3 실적을 보고했습니다. 회사는 기간에 대해 매출 약 620만 달러US GAAP 기준 영업비용 약 580만~590만 달러를 추정합니다.

분기 말 유동성은 제한적이었고 현금 및 현금성 자산은 2025년 9월 30일 현재 약 200만 달러였습니다. 회사는 또한 현금 및 현금성 자산과 단기투자 잔액이 같은 날짜에 약 200만 달러였다고 밝혔습니다.

경영진은 이 수치를 작성했으며 분기 말 마감 절차의 일반적 절차에 따라 변경될 수 있습니다. 회사의 독립 감사인 EY는 이 결과를 감사, 검토 또는 편집하지 않았습니다. 실제 결과는 향후 Form 10-Q에 표시될 예정입니다. 이 정보는 항목 2.02에 따라 제공되었으며 Exchange Act에 따라 제출된 것으로 간주되지 않습니다.

Lifeward Ltd. (LFWD) a déclaré des résultats préliminaires non audités du T3 pour le trimestre se terminant le 30 septembre 2025. La société estime un chiffre d'affaires d'environ 6,2 millions de dollars et des coûts opérationnels selon les principes comptables généralement admis aux États-Unis (US GAAP) d'environ 5,8–5,9 millions de dollars pour la période.

La liquidité à la fin du trimestre était limitée, avec des liquidités et équivalents d'environ 2,0 millions de dollars au 30 septembre 2025. La société a également indiqué que son solde de liquidités, équivalents de liquidité et investissements à court terme était d'environ 2,0 millions de dollars à la même date.

La direction a préparé ces chiffres et ils sont soumets aux procédures habituelles de clôture du trimestre, ce qui pourrait modifier les montants. L'auditeur indépendant de la société, EY, n'a pas audité, révisé ou compilé ces résultats. Les résultats réels apparaîtront dans le prochain Formulaire 10-Q. L'information a été fournie en vertu de l'Item 2.02 et n'est pas considérée comme déposée en vertu de la Exchange Act.

Lifeward Ltd. (LFWD) berichtete vorläufige, unprüfte Q3-Ergebnisse für das Quartal zum 30. September 2025. Das Unternehmen schätzt einen Umsatz von ca. 6,2 Mio. USD und US-GAAP-Betriebsausgaben von ca. 5,8–5,9 Mio. USD für den Zeitraum.

Liquidität zum Quartalsende war begrenzt, mit Barmitteln und Barmitteläquivalenten von ca. 2,0 Mio. USD zum 30. September 2025. Das Unternehmen gab außerdem an, dass sein Saldo an Barmitteln, Barmitteläquivalenten und kurzfristigen Investitionen zum selben Datum ca. 2,0 Mio. USD betrug.

Das Management hat diese Zahlen erstellt und sie unterliegen den üblichen Quartalsabschlussverfahren, die die Beträge ändern könnten. Der unabhängige Prüfer EY hat diese Ergebnisse nicht geprüft, überprüft oder zusammengestellt. Die tatsächlichen Ergebnisse werden im kommenden Form 10-Q erscheinen. Die Informationen wurden gemäß Item 2.02 bereitgestellt und gelten nicht als gemäß der Exchange Act eingereicht.



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): October 16, 2025
 
Lifeward Ltd.

(Exact Name of Registrant as Specified in its Charter)
  
Israel
 
001-36612
 
Not Applicable
(State or Other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

200 Donald Lynch Blvd. Marlborough, MA
 
01752
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: +508.251.1154
  
Not applicable
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
Ordinary Shares, par value NIS 1.75
 
LFWD
 
Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


Item 2.02 Results of Operations and Financial Condition.

Preliminary Financial Results

On October 16, 2025, Lifeward Ltd. (the “Company”) announced its preliminary revenue results of approximately $6.2 million for the quarter ended September 30, 2025 and its preliminary U.S. GAAP operating expenses in the range of approximately $5.8 million to $5.9 million. The Company’s cash and cash equivalents as of September 30, 2025 was approximately $2.0 million. These unaudited, preliminary amounts have been prepared by and are the responsibility of management. These amounts are based upon information available to management as of the date of this Current Report on Form 8-K and subject to completion of customary quarter-end close procedures and financial review that could result in changes to the amounts. Furthermore, these amounts do not present all information necessary for an understanding of the Company’s financial condition as of September 30, 2025 or its results of operations as of such date. The Company’s independent registered public accounting firm, Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (“EY”), has not audited, reviewed, compiled or performed any procedures with respect to these preliminary financial results and, accordingly, EY does not express an opinion or any other form of assurance with respect thereto. The Company’s actual results for the quarter ended September 30, 2025 will be included in its Quarterly Report on Form 10-Q and may differ materially from the above estimate.

The Company’s cash, cash equivalent and short-term investment balance as of September 30, 2025 is approximately $2.0 million.

The information disclosed in this Item 2.02 is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Lifeward Ltd.
 
 
 
 
 
Dated: October 16, 2025
By:
/s/ Almog Adar
 
 
Name:
Almog Adar
 
 
Title:
Chief Financial Officer
 


graphic

FAQ

What preliminary Q3 2025 revenue did Lifeward (LFWD) report?

Lifeward estimates approximately $6.2 million in revenue for the quarter ended September 30, 2025.

What were Lifeward’s preliminary operating expenses for Q3 2025?

U.S. GAAP operating expenses are estimated at approximately $5.8–$5.9 million for the quarter.

How much cash did Lifeward have at quarter-end Q3 2025?

Cash and cash equivalents were approximately $2.0 million as of September 30, 2025.

Are Lifeward’s preliminary results audited or reviewed by EY?

No. EY has not audited, reviewed, or compiled the preliminary results.

Where will Lifeward’s final Q3 2025 results be reported?

Final results will be included in the company’s upcoming Form 10‑Q.

Is this disclosure considered filed under the Exchange Act?

No. The information was furnished under Item 2.02 and is not deemed filed.
Lifeward Ltd

NASDAQ:LFWD

LFWD Rankings

LFWD Latest News

LFWD Latest SEC Filings

LFWD Stock Data

10.68M
15.42M
2.07%
2.89%
7.44%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Israel
MARLBOROUGH